462 results
8-K
EX-99.1
LLY
Lilly(Eli) & Co
30 Apr 24
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
7:04am
of the company's operations which may exacerbate competitive, regulatory, litigation, cybersecurity, and other risks; the impact of global macroeconomic … rates and inflation; litigation, investigations, or other similar proceedings involving past, current, or future products or activities; changes
PX14A6G
As You Sow
11 Apr 24
Letter to shareholders
12:59pm
that ineffective DEI initiatives are leading to significant unnecessary costs being borne to recruit and train diverse employees and that litigation risk may
PX14A6G
Trinity Health Corp
28 Mar 24
Letter to shareholders
12:20pm
federal district courts across the country already apply to limit the number of patents or patent claims a company can assert in litigation … .
Specifically, this bipartisan bill:
Streamlines patent litigation by limiting to one, the number of patents per patent thicket a pharmaceutical company can
8-K
EX-1.1
ox9ey 68mtec
9 Feb 24
Other Events
11:56am
424B2
zgp8ddq9q5nxjc
8 Feb 24
Prospectus for primary offering
4:51pm
424B2
7fkw5hn2ntzlt5
7 Feb 24
Prospectus for primary offering
8:12am
8-K
EX-99.1
y0856 db5a65xr5f
6 Feb 24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
7:04am
CORRESP
rgpxyk 8c4wfp
9 Nov 23
Correspondence with SEC
12:00am
SC TO-T/A
sp5il9gb299dst154r
8 Nov 23
Third party tender offer statement (amended)
5:06pm
8-K
EX-99.1
yw5hrdb hvsxmbj03bk
2 Nov 23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
7:02am
SC TO-T/A
jmmbi49hg7
27 Oct 23
Third party tender offer statement (amended)
4:15pm
SC TO-T
EX-99
1k0imdi
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
rlym59zlx
13 Oct 23
Third party tender offer statement
6:52am